Phylo is a pioneering applied research lab focused on harnessing AI to revolutionize biomedical research. By studying agentic intelligence, Phylo aims to facilitate scientific discoveries at an unprecedented pace, enhancing the capabilities of every biomedical scientist. The lab has introduced Biomni Lab, a state-of-the-art platform that accelerates research and fosters innovation in the field.

Co-founded by visionaries Kexin Huang and Yuanhao Qu, the team at Phylo consists of leading researchers, engineers, and scientists who are dedicated to advancing the integration of AI in medicine. Their mission is clear: transform the landscape of biomedical research through the power of intelligent agents. Phylo has also attracted significant investment, co-led by prominent firms such as A16Z and Menlo, underscoring its potential to significantly impact the biomedical industry.

With a commitment to evolving technology and discovery, Phylo stands at the forefront of biomedical innovation, poised to redefine how research is conducted in the life sciences